Early breast cancer without metastasis is potentially curable: resection of the tumor is a viable option for every patient, and primary radiotherapy and systemic therapy such as chemotherapy may be more appropriate for TNBC or HER2-positive breast cancer [21]. This evidence concerns the gene ERBB2 and breast carcinoma.